A review on favipiravir: the properties, function, and usefulness to treat COVID-19

SMR Hashemian, T Farhadi… - Expert review of anti …, 2021 - Taylor & Francis
Introduction At this time, there is no specific therapeutic or vaccine for treatment of the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Hence, available drugs for …

Antiviral drugs against severe fever with thrombocytopenia syndrome virus infection

M Takayama-Ito, M Saijo - Frontiers in Microbiology, 2020 - frontiersin.org
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne infectious
disease caused by SFTS virus (SFTSV), which is a novel bunyavirus. SFTSV was first …

Baseline mapping of severe fever with thrombocytopenia syndrome virology, epidemiology and vaccine research and development

NE Bopp, JA Kaiser, AE Strother, ADT Barrett… - NPJ vaccines, 2020 - nature.com
Severe fever with thrombocytopenia syndrome virus (SFTSV) is a newly emergent tick-borne
bunyavirus first discovered in 2009 in China. SFTSV is a growing public health problem that …

Emerging Tick-Borne Dabie bandavirus: Virology, Epidemiology, and Prevention

EH Kim, SJ Park - Microorganisms, 2023 - mdpi.com
Severe Fever with Thrombocytopenia Syndrome (SFTS), caused by Dabie bandavirus
(SFTSV), is an emerging infectious disease first identified in China. Since its discovery …

Animal model of severe fever with thrombocytopenia syndrome virus infection

J Sun, YQ Min, Y Li, X Sun, F Deng, H Wang… - Frontiers in …, 2022 - frontiersin.org
Severe fever with thrombocytopenia syndrome (SFTS), an emerging life-threatening
infectious disease caused by SFTS bunyavirus (SFTSV; genus Bandavirus, family …

An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus

KH Kim, J Kim, M Ko, JY Chun, H Kim, S Kim… - PLoS …, 2019 - journals.plos.org
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease
localized to China, Japan, and Korea that is characterized by severe hemorrhage and a high …

Structural mechanism of CRL4‐instructed STAT2 degradation via a novel cytomegaloviral DCAF receptor

VTK Le‐Trilling, S Banchenko, D Paydar… - The EMBO …, 2023 - embopress.org
Human cytomegalovirus (CMV) is a ubiquitously distributed pathogen whose rodent
counterparts such as mouse and rat CMV serve as common infection models. Here, we …

[HTML][HTML] Severe fever with thrombocytopenia syndrome virus induces platelet activation and apoptosis via a reactive oxygen species-dependent pathway

YH Li, XH Wang, WW Huang, RR Tian, W Pang… - Redox Biology, 2023 - Elsevier
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne infectious
disease caused by the SFTS virus (SFTSV) and with a high fatality rate. Thrombocytopenia …

In vitro and in vivo efficacy of a novel nucleoside analog H44 against Crimean–Congo hemorrhagic fever virus

Q Wang, R Cao, L Li, J Liu, J Yang, W Li, L Yan… - Antiviral research, 2022 - Elsevier
Crimean–Congo hemorrhagic fever virus (CCHFV) is a highly pathogenic tick-borne virus
that causes fever, hemorrhage, and multi-organ failure, with an average fatality rate of∼ …

RIG-I-like receptor and toll-like receptor signaling pathways cause aberrant production of inflammatory cytokines/chemokines in a severe fever with thrombocytopenia …

S Yamada, M Shimojima, R Narita… - Journal of …, 2018 - Am Soc Microbiol
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease
caused by a tick-borne phlebovirus of the family Bunyaviridae, SFTS virus (SFTSV). Wild …